Gerrit  Klaerner net worth and biography

Gerrit Klaerner Biography and Net Worth

CEO of Tricida
Dr. Gerrit Klaerner, Ph.D., the Founder of the Company, has served as a member of our board of directors since July 2013 and as our Chief Executive Officer and President since August 2013. Dr. Klaerner was the Founder of Relypsa, Inc. and served as its President and as a member of its board of directors from October 2007 until June 2013. Dr. Klaerner co-founded Ilypsa, Inc. in 2003 and served as its Chief Business Officer and Senior Vice President from December 2006 until July 2007 and its Director of Technology Assessment and Business Development from January 2003 until December 2006. Dr. Klaerner served in Symyx Technologies, Inc. from October 1998 until January 2003 as Staff Scientist, Senior Staff Scientist and Director of Business Development. Dr. Klaerner received his Ph.D. in polymer and organic chemistry from the Max Planck Institute for Polymer Research in Mainz, Germany, his M.S. in Chemistry from the Philipps University of Marburg and completed post-doctoral research at Stanford University and the IBM Almaden Research Center.

What is Gerrit Klaerner's net worth?

The estimated net worth of Gerrit Klaerner is at least $0.00 as of January 14th, 2021. Dr. Klaerner owns 509,648 shares of Tricida stock worth more than $0 as of March 28th. This net worth evaluation does not reflect any other investments that Dr. Klaerner may own. Learn More about Gerrit Klaerner's net worth.

How do I contact Gerrit Klaerner?

The corporate mailing address for Dr. Klaerner and other Tricida executives is 7000 SHORELINE COURT SUITE 201, SOUTH SAN FRANCISCO CA, 94080. Tricida can also be reached via phone at (415) 429-7800 and via email at [email protected]. Learn More on Gerrit Klaerner's contact information.

Has Gerrit Klaerner been buying or selling shares of Tricida?

Gerrit Klaerner has not been actively trading shares of Tricida during the past quarter. Most recently, Gerrit Klaerner sold 8,000 shares of the business's stock in a transaction on Wednesday, December 8th. The shares were sold at an average price of $7.84, for a transaction totalling $62,720.00. Learn More on Gerrit Klaerner's trading history.

Who are Tricida's active insiders?

Tricida's insider roster includes Sandra Coufal (Director), and Gerrit Klaerner (CEO). Learn More on Tricida's active insiders.

Gerrit Klaerner Insider Trading History at Tricida

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/8/2021Sell8,000$7.84$62,720.00View SEC Filing Icon  
11/15/2021Sell126,000$6.02$758,520.00View SEC Filing Icon  
1/14/2021Sell16,690$7.39$123,339.10509,648View SEC Filing Icon  
1/11/2021Sell21,489$7.49$160,952.61534,504View SEC Filing Icon  
7/15/2020Sell4,000$26.33$105,320.00View SEC Filing Icon  
7/1/2020Sell4,000$27.15$108,600.00547,321View SEC Filing Icon  
6/15/2020Sell4,000$25.97$103,880.00551,321View SEC Filing Icon  
5/15/2020Sell4,000$31.56$126,240.00555,321View SEC Filing Icon  
5/1/2020Sell4,000$27.98$111,920.00556,271View SEC Filing Icon  
4/15/2020Sell4,000$27.47$109,880.00559,321View SEC Filing Icon  
4/6/2020Sell4,000$24.22$96,880.00559,321View SEC Filing Icon  
3/16/2020Sell4,000$23.91$95,640.00563,321View SEC Filing Icon  
3/2/2020Sell4,000$31.53$126,120.00563,321View SEC Filing Icon  
1/15/2020Sell4,000$35.26$141,040.00571,321View SEC Filing Icon  
12/18/2019Sell31,750$38.91$1,235,392.50575,321View SEC Filing Icon  
12/10/2019Sell3,948$43.28$170,869.44582,893View SEC Filing Icon  
12/2/2019Sell4,000$39.49$157,960.00590,841View SEC Filing Icon  
11/29/2019Sell2,000$39.80$79,600.00590,841View SEC Filing Icon  
10/28/2019Sell4,000$37.41$149,640.00
9/30/2019Sell10,255$30.69$314,725.95
8/28/2019Sell4,000$33.71$134,840.00652,119View SEC Filing Icon  
7/29/2019Sell4,000$31.17$124,680.00View SEC Filing Icon  
7/8/2019Sell5,826$35.55$207,114.30View SEC Filing Icon  
3/28/2019Sell57,822$32.96$1,905,813.12View SEC Filing Icon  
3/4/2019Sell8,000$23.92$191,360.00View SEC Filing Icon  
See Full Table

Gerrit Klaerner Buying and Selling Activity at Tricida

This chart shows Gerrit Klaerner's buying and selling at Tricida by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tricida Company Overview

Tricida logo
Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.13
Low: $0.11
High: $0.19

2 Week Range

Now: N/A

Volume

31,125,300 shs

Average Volume

17,618,414 shs

Market Capitalization

$6.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.22